Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDX5791 (tenapanor) in IBS-C
NCT01340053Phase 2Completed
- Sponsor
- Ardelyx
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenapanor in irritable bowel syndrome (IBS), sponsored by Ardelyx. Started May 2011; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01340053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340053.